Location History:
- Tsukuba, JP (2011 - 2016)
- Ibaraki, JP (2001 - 2018)
Company Filing History:
10 out of 273 
1 out of 340 
1 out of 371 
Years Active: 2001-2018
Title: Mikio Niwa: Innovator in Synthetic Peptide Technology
Introduction
Mikio Niwa is a prominent inventor based in Tsukuba, Japan, known for his significant contributions to the field of synthetic peptides. With a total of 10 patents to his name, Niwa has made remarkable advancements in cellular reprogramming and TNF receptor expression.
Latest Patents
One of Niwa's latest patents is focused on a synthetic peptide that induces the reprogramming of differentiated cells. This invention includes a pharmaceutical composition that utilizes the synthetic peptide to produce undifferentiated cells from differentiated ones. The peptide sequence is defined by a specific amino acid sequence, allowing for targeted cellular reprogramming. Another notable patent involves a TNFR2 expression-inducing composition, which comprises a peptide that enhances the expression of TNF receptor 2 in cells. This method includes culturing cells capable of expressing TNF receptor 2 and supplying them with a synthetic peptide that contains a nuclear localization signal sequence or a nucleolar localization signal sequence.
Career Highlights
Throughout his career, Mikio Niwa has worked with esteemed organizations such as Toagosei Company, Ltd. and Keio University. His work in these institutions has allowed him to further his research and development in synthetic peptide technology.
Collaborations
Niwa has collaborated with notable colleagues, including Tetsuhiko Yoshida and Nahoko Kobayashi. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Mikio Niwa's innovative work in synthetic peptides has paved the way for new methods in cellular reprogramming and therapeutic applications. His contributions continue to impact the field significantly.